Skip to main content

Olumiant (baricitinib) and Alcohol/Food Interactions

There is 1 alcohol/food/lifestyle interaction with Olumiant (baricitinib):


High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)

Moderate Potential Hazard, Moderate plausibility

baricitinib - hyperlipemia

In controlled clinical trials, baricitinib treatment was associated with dose-related increases in lipid parameters including total cholesterol, triglycerides, LDL cholesterol, and HDL cholesterol. It is recommended to evaluate lipid parameters at baseline and approximately 12 weeks following initiation of treatment. Manage patients according to clinical guidelines for the management of hyperlipidemia.

Olumiant (baricitinib) drug interactions

There are 364 drug interactions with Olumiant (baricitinib)

Olumiant (baricitinib) disease interactions

There are 11 disease interactions with Olumiant (baricitinib) which include:

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.